RW Effectiveness of Lurbinectedin in Extensive Stage SCLC

NCT05285033 · clinicaltrials.gov ↗

COMPLETED

Status

312

Enrollment

OTHER

Sponsor class

Conditions

Small-cell Lung Cancer

Interventions

DRUG: Lurbinectedin

Sponsor

Intergroupe Francophone de Cancerologie Thoracique

Collaborators

[object Object]
[object Object]